Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02462239
What this trial is testing

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

Who this might be right for
Muscle-invasive Bladder Cancer
Ontario Clinical Oncology Group (OCOG) 292
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Early research (Phase 1)Active Not RecruitingNCT04963153
What this trial is testing

Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+17 more
National Cancer Institute (NCI) 24
Very early researchStudy completedNCT04018053
What this trial is testing

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Who this might be right for
Bladder CancerUrothelial Carcinoma
Brigham and Women's Hospital 16
Testing effectiveness (Phase 2)UnknownNCT01215877
What this trial is testing

Tesetaxel for Previously Treated Patients With Bladder Cancer

Who this might be right for
Carcinoma, Transitional Cell
Genta Incorporated 33
Testing effectiveness (Phase 2)Study completedNCT02351739
What this trial is testing

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer

Who this might be right for
Metastatic Urothelial Carcinoma
Acerta Pharma BV 78
Testing effectiveness (Phase 2)Ended earlyNCT01118351
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Who this might be right for
Recurrent Bladder CancerTransitional Cell Carcinoma of the Bladder
Case Comprehensive Cancer Center 19
Very early researchStudy completedNCT03473730
What this trial is testing

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Who this might be right for
Bladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT02665039
What this trial is testing

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 62
Testing effectiveness (Phase 2)UnknownNCT03560479
What this trial is testing

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Hamlet Pharma AB 52
Testing effectiveness (Phase 2)Study completedNCT00028860
What this trial is testing

Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Tulane University Health Sciences Center
Not applicableLooking for participantsNCT06310759
What this trial is testing

Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Tampere University Hospital 3,000
Not applicableUnknownNCT05337189
What this trial is testing

Clinical Trial of Urine DNA Testing for Bladder Cancer in China

Who this might be right for
Bladder CancerUrocystitisUrinary Bladder Stone+1 more
Creative Biosciences (Guangzhou) Co., Ltd. 482
Testing effectiveness (Phase 2)UnknownNCT02547350
What this trial is testing

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

Who this might be right for
Upper Tract Urothelial CarcinomaBladder Recurrence
Xuesong Li 200
Testing effectiveness (Phase 2)Looking for participantsNCT05296564
What this trial is testing

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Who this might be right for
Sarcoma, SynovialSarcoma,Soft TissueMelanoma Stage IV+6 more
Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Ended earlyNCT03389438
What this trial is testing

Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Neoplasm
Beijing Huanxing Cancer Hospital 6
Not applicableStudy completedNCT05945108
What this trial is testing

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Who this might be right for
Urothelial CarcinomaNon Muscle Invasive Bladder CancerMuscle-invasive Bladder Cancer
AstraZeneca 400
Early research (Phase 1)Looking for participantsNCT06766266
What this trial is testing

Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment

Who this might be right for
Non-Muscle Invasive Bladder Urothelial Carcinoma
First Affiliated Hospital of Chongqing Medical University 18
Not applicableNot Yet RecruitingNCT06901934
What this trial is testing

JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes

Who this might be right for
Urothelial Carcinoma Bladder
Zeinab Yahia Zaki 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06331299
What this trial is testing

UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 99
Next Page